Goldman Sachs' Ankang Li heads to biotech Terns as new CFO; SV recruits new partner for Dementia Discovery Fund
→ Fresh off a NASH deal with French drugmaker Genfit, Terns Pharma has appointed
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
